Regenerative Therapies: PRP and Stem Cell Therapy: Ideal Remedy to Remove Pain in Arthritic Joints

Wednesday 23 July 2014

PRP and Stem Cell Therapy: Ideal Remedy to Remove Pain in Arthritic Joints

Platelet Rich Plasma (PRP) Therapy to End Joint Pain

Platelet Rich Plasma therapy is recommended to patients who are suffering from intense pain in the musculoskeletal system. This therapy is rapidly developing to offer both men and women permanent relieve from any kind of joint or arthritis pain and discomfort. PRP therapy is done in the knees, shoulders, ankles, hips, back, and such other body parts to help an athlete or a non-athlete walk, run and move properly and perform daily tasks without any problem. 

How the treatment is Conducted?

Trained doctors only perform such a Platelet Rich Plasma therapy. A doctor collects a small amount of blood from the patient’s body and then takes it to the lab to separate the platelets from the other components. The concentrated PRP is then injected into the damaged area of the patient without any kind of surgery. Such a treatment procedure is safe with no side effects since the donor and the recipient are the same person. Chances of infections or diseases are eliminated. PRP treatment is clinically approved and has received much praise for helping a person quickly recover from pain. Studies have shown this therapy to be highly effective for tissues repair and accelerating the healing process. 

How long will the treatment take?

The Platelet Rich Plasma therapy is very fast and gets completed within 1 to 2 hours. There are many high profile clinics in USA especially in Los Angeles and Hollywood where certified trained doctors perform this therapy using advanced instruments and technology.  The procedure is almost pain-free since it is non-surgical in nature. Patients are guaranteed quick recovery after PRP injections are given into the damaged knee, hip, back, shoulder, and ankle. Also, PRP cell injection is given for regeneration of the skin and increasing collagen production. 

No comments:

Post a Comment